These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23091058)

  • 61. Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation.
    Tanner MA; Thomas TP; Grisanti LA
    J Mol Cell Cardiol; 2019 Nov; 136():1-14. PubMed ID: 31473246
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FNDC5/Irisin inhibits pathological cardiac hypertrophy.
    Yu Q; Kou W; Xu X; Zhou S; Luan P; Xu X; Li H; Zhuang J; Wang J; Zhao Y; Xu Y; Peng W
    Clin Sci (Lond); 2019 Mar; 133(5):611-627. PubMed ID: 30782608
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cardiac myocyte p38α kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart.
    Rose BA; Yokota T; Chintalgattu V; Ren S; Iruela-Arispe L; Khakoo AY; Minamisawa S; Wang Y
    J Biol Chem; 2017 Aug; 292(31):12787-12800. PubMed ID: 28637870
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
    Kang S; Chemaly ER; Hajjar RJ; Lebeche D
    J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy.
    Kovacic-Milivojević B; Roediger F; Almeida EA; Damsky CH; Gardner DG; Ilić D
    Mol Biol Cell; 2001 Aug; 12(8):2290-307. PubMed ID: 11514617
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ninjurin1 regulates striated muscle growth and differentiation.
    Kny M; Csályi KD; Klaeske K; Busch K; Meyer AM; Merks AM; Darm K; Dworatzek E; Fliegner D; Baczko I; Regitz-Zagrosek V; Butter C; Luft FC; Panáková D; Fielitz J
    PLoS One; 2019; 14(5):e0216987. PubMed ID: 31091274
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relation of Cardiotrophin-1 (CT-1) and cardiac transcription factor GATA4 expression in rat's cardiac myocytes hypertrophy and apoptosis.
    He-nan Z; Yan W; Miao-na J; Cai-hua Z; Shen L; Yu-jie J
    Pathol Res Pract; 2009; 205(9):615-25. PubMed ID: 19327894
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy.
    Oceandy D; Pickard A; Prehar S; Zi M; Mohamed TM; Stanley PJ; Baudoin-Stanley F; Nadif R; Tommasi S; Pfeifer GP; Armesilla AL; Cartwright EJ; Neyses L
    Circulation; 2009 Aug; 120(7):607-16. PubMed ID: 19652091
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
    Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling.
    Yuan Y; Wang J; Chen Q; Wu Q; Deng W; Zhou H; Shen D
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1421-1427. PubMed ID: 30794866
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
    Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
    Lijnen P; Petrov V
    J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling.
    Dierck F; Kuhn C; Rohr C; Hille S; Braune J; Sossalla S; Molt S; van der Ven PFM; Fürst DO; Frey N
    J Biol Chem; 2017 Sep; 292(37):15180-15191. PubMed ID: 28717008
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Egr-1 mediated cardiac miR-99 family expression diverges physiological hypertrophy from pathological hypertrophy.
    Ramasamy S; Velmurugan G; Rekha B; Anusha S; Shanmugha Rajan K; Shanmugarajan S; Ramprasath T; Gopal P; Tomar D; Karthik KV; Verma SK; Garikipati VNS; Sudarsan R
    Exp Cell Res; 2018 Apr; 365(1):46-56. PubMed ID: 29481791
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy.
    Wang S; Cheng M; Hu Z; Hu S; Zou Q; Lai X; Liu B; Jiang H; Huang C; Wu G
    Cell Physiol Biochem; 2017; 44(6):2281-2295. PubMed ID: 29262413
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hypothetical pathways of cardiac myocyte hypertrophy: response to myocardial injury.
    Francis GS; Carlyle WC
    Eur Heart J; 1993 Nov; 14 Suppl J():49-56. PubMed ID: 8281963
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
    Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
    J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.